Johnson & Johnson ordered to pay $18.8 million to California Talc-Cancer Trial victim
Johnson & Johnson was ordered to pay $18.8 million to a California man who claimed the company's talcum-based powders caused his cancer.
Johnson & Johnson
Stay updated with the latest news and articles about Johnson & Johnson.
Latest Articles
Aspen Pharmacare, Johnson & Johnson announce deal to produce COVID-19 vaccine candidate
South African pharmaceutical company Aspen Pharmacare on Tuesday announced its deal with the American firm Johnson & Johnson to jointly manufacture its COVID-19 vaccine candidate 'Ad26.COV3-S'. The manufacture of the vaccine is subject to its approval internationally and in South Africa.
COVID-19 Vaccine: Johnson & Johnson to start human trials in July
Johnson & Johnson will start human trials in July for the COVID-19 Vaccine. It has moved up the human clinical trial dates for testing. In conclusion, it is set to happen two months to the second half of July. Because, the drug maker rushes to develop a prevention for COVID-19. Stated company officials on 10th June.